Literature DB >> 6884431

Antiarrhythmic evaluation of naloxone against acute coronary occlusion-induced arrhythmias in pigs.

J L Bergey, M E Beil.   

Abstract

Naloxone pretreatment (1.0, 3.0 and 10.0 mg/kg i.v.) failed to protect anesthetized pigs from cardiac arrhythmias including ventricular fibrillation (VF) and death following acute occlusion (20 min) or reperfusion of the left anterior descending coronary artery. These findings suggest that opiate-like substances possibly released by the ischemic myocardium do not contribute significantly to the etiology of cardiac arrhythmias, or sudden death associated with the early stages of myocardial infarction in pigs. The effectiveness of naloxone in preventing acute ischemia-induced arrhythmias in rats may be due to mechanisms other than opiate-receptor blockade.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884431     DOI: 10.1016/0014-2999(83)90566-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Failure to reproduce the in vitro cardiac electrophysiological effects of naloxone in humans.

Authors:  K G Oldroyd; A C Rankin; C E Gray; K Harvey; W Borland; A P Rae; S M Cobbe
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

2.  Influence of the optical isomers (+)- and (-)-naloxone on beating frequency, contractile force and action potentials of guinea-pig isolated cardiac preparations.

Authors:  H Brasch
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

3.  Naloxone inhibits arrhythmias induced by coronary artery occlusion and reperfusion in anaesthetized dogs.

Authors:  X D Huang; A Y Lee; T M Wong; C Y Zhan; Y Y Zhao
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

4.  Stereospecific antiarrhythmic effects of naloxone against myocardial ischaemia and reperfusion in the dog.

Authors:  A Y Lee
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.